CODXNasdaq

Co-Diagnostics Inc.

Healthcare·Neurology·Commercial·Salt Lake City, UT, United States
NeurologyImmunologyOphthalmologyCardiovascularInfectious Disease

Co-Diagnostics Inc. (CODX): 24 pipeline candidates · ~3 mo cash runway. Updated within the last hour.

7.6/10

BioSniper Score

4-factor signal · derived from public data

Cash Runway0.9

3.3 months

Financial Health9.5

D/E 0.34 · 0% dilution

Pipeline Maturity10.0

Lead: Approved

Pipeline Breadth10.0

24 candidates

Catalyst MomentumN/A

N/A

Insider SignalN/A

N/A

A transparent, data-derived signal for Co-Diagnostics Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.

Key Financials

Market Cap

$15.7M

Cash

$8.2M

Quarterly Burn

$7.8M

Runway

3.3 mo

Revenue

$146K

Cash Runway vs Catalysts

Tracked catalysts land within the current projected cash runway.

Cash ends ~Sep 2026
Today~7 mo out
Catalyst within runway

Pipeline (24 candidates)

Showing 10 of 24 candidates. Sign up for full pipeline.

Institutional Holdings

Source: SEC Form 13F · as of Mar 2026

Institutional holders

7

Total value held

$354

HolderSharesValue
morgan stanley88$164
wells fargo & company/mn81$151
osaic holdings, inc.10$18
danske bank a/s7$13
harbour investments, inc.2$4
citigroup inc1$2
vanguard fiduciary trust co1$2
·CEO: Mr. Dwight H. Egan

Frequently asked questions

How many drug candidates are in Co-Diagnostics Inc.'s pipeline?

Co-Diagnostics Inc. (CODX) has 24 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.

What is Co-Diagnostics Inc.'s lead drug candidate?

Co-Diagnostics Inc.'s most advanced tracked candidate is absorbable dusting (Approved) for General Hospital.

What is Co-Diagnostics Inc.'s cash runway?

Based on its most recent reported cash balance and quarterly burn rate, Co-Diagnostics Inc. has approximately 3.3 months of cash runway.

What is Co-Diagnostics Inc.'s market capitalization?

Co-Diagnostics Inc.'s market capitalization is approximately $15.7M.

Who is the CEO of Co-Diagnostics Inc.?

Mr. Dwight H. Egan is the chief executive officer of Co-Diagnostics Inc. (CODX).

Get the full picture on Co-Diagnostics Inc.

Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.